Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 50 results: Page 1 of 2


Tier Species Size Attr. GeneSet
Tier I 124 GS268609: GWAS Catalog Data for age-related hearing impairment in 1,489 European ancestry individuals
Tier I 4 GS269160: GWAS Catalog Data for CCL5 measurement in 815 Hispanic children from 263 families
Tier IV 1861 GS399883: Upreg
Tier IV 718 GS403351: Genes with downregulated whole blood RNA levels in children with COVID-19 versus healthy controls
Tier IV 9412 GS404756: Up regulated genes from caudate nucleus (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 8883 GS404759: Up regulated genes from putamen (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 8406 GS404762: Up regulated genes from ventral striatum from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier IV 169 GS408222: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_log2FC
Tier IV 169 GS408223: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_qvalue
Tier IV 17285 GS408225: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_metaanalysis_qvalue
Tier IV 54 GS408226: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Seney et al 2021_log2FC
Tier IV 54 GS408227: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Seney et al 2021_qvalue
Tier IV 133 GS408228: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Sosnowski et al 2022_log2FC
Tier IV 133 GS408230: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Sosnowski et al 2022_qvalue
Tier III 9636 GS409002: Differentially expressed genes in post-mortem human cuadate nucleus astrocytes of cocaine use disorder (CocUD) vs. control (p < 0.05)_pvalue
Tier III 9636 GS409003: Differentially expressed genes in post-mortem human cuadate nucleus astrocytes of cocaine use disorder (CocUD) vs. control (p < 0.05)_avg log2FC
Tier III 9636 GS409004: Differentially expressed genes in post-mortem human cuadate nucleus astrocytes of cocaine use disorder (CocUD) vs. control (p < 0.05)_qvalue
Tier III 9636 GS409005: Differentially expressed genes in post-mortem human cuadate nucleus D1 MSN of cocaine use disorder (CocUD) vs. control (p < 0.05)_pvalue